AnticoagEvaluator 17+
American College of Cardiology
專為 iPad 設計
-
- 免費
螢幕截圖
描述
Make well-informed decisions on antithrombotic therapy for your non-valvular AF patients with the updated AnticoagEvaluator.
Use the app to:
• Calculate a patient's renal function and risk of ischemic stroke, thromboembolism, and bleed
• Review ACC/AHA/HRS Guideline-driven therapy guidance for stroke prevention
• Generate individualized risk for antithrombotic therapy options based on individual clinical trials.
• Improve accurate use of DOACs with adjusted dosage based on prescribing information, fine-tuned for renal and other patient characteristics.
This app is based on SPARC Tool, developed by Peter Loewen, ACPR, Pharm.D., FCSHP, which can be viewed at www.sparctool.com
最新功能
版本 4.3
This app has been updated in accordance with the 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation to incorporate additional stroke risk models (ATRIA, GARFIELD), a mortality risk model (GARFIELD), and updates to the existing stroke and bleed risk calculations. This update also includes updated therapy guidance and renal-adjusted therapy dosing information.
App 私隱
開發者表明American College of Cardiology的私隱慣例或包括下列資料的處理。詳情請參閱開發者的私隱政策。
不會與你連結的資料
開發者可能會收集以下資料，但不會連結你的個人身份：
- 使用資料
私隱慣例或因使用的功能或年齡等因素而異。進一步了解
資料
- 供應商
- American College of Cardiology
- 大小
- 25.9 MB
- 類別
- 醫藥
- 兼容性
-
- iPhone
- 須使用 iOS 11.0 或以上版本。
- iPad
- 須使用 iPadOS 11.0 或以上版本。
- iPod touch
- 須使用 iOS 11.0 或以上版本。
- Mac
- 須使用 macOS 11.0 或以上版本及配備 Apple M1 或以上版本晶片的 Mac。
- Apple Vision
- 須使用 visionOS 1.0 或以上版本。
- 語言
-
英文
- 年齡
- 17+ 頻繁/極度的藥物或治療資訊
- Copyright
- © 2024 American College of Cardiology
- 價格
- 免費